These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24885767)

  • 21. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
    Babar ZU; Lessing C; Mace C; Bissell K
    Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prices & availability of common medicines at six sites in India using a standard methodology.
    Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
    Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [International reference prices and cost minimization analysis for the regulation of medicine prices in Colombia].
    Vacca C; Acosta A; Rodriguez I
    Value Health; 2011; 14(5 Suppl 1):S16-9. PubMed ID: 21839891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prices people pay for medicines in Zimbabwe.
    Gavaza P; Simoyi T; Makunike B; Maponga CC
    Cent Afr J Med; 2009; 55(1-4):14-9. PubMed ID: 21977842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.
    Rand LZ; Kesselheim AS
    Value Health; 2021 Apr; 24(4):473-476. PubMed ID: 33840424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pricing of HPV vaccines in European tender-based settings.
    Qendri V; Bogaards JA; Berkhof J
    Eur J Health Econ; 2019 Mar; 20(2):271-280. PubMed ID: 30051152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
    Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
    Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data.
    van Mourik MS; Cameron A; Ewen M; Laing RO
    BMC Cardiovasc Disord; 2010 Jun; 10():25. PubMed ID: 20534118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affordable Prices Without Threatening the Oncological R&D Pipeline-An Economic Experiment on Transparency in Price Negotiations.
    Franzen N; Ziegler A; Romagnoli G; Retèl VP; Offerman TJS; van Harten WH
    Cancer Res Commun; 2022 Jan; 2(1):49-57. PubMed ID: 36860697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014.
    Hamzah NM; Perera PN; Rannan-Eliya RP
    BMC Health Serv Res; 2020 Jun; 20(1):509. PubMed ID: 32503539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America.
    Wirtz VJ; Santa-Ana-Tellez Y; Trout CH; Kaplan WA
    Health Policy Plan; 2012 Dec; 27(8):638-48. PubMed ID: 22367770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prices, availability and affordability of medicines in Rwanda.
    Bizimana T; Kayumba PC; Heide L
    PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International drug price comparisons: quality assessment.
    Machado M; O'Brodovich R; Krahn M; Einarson TR
    Rev Panam Salud Publica; 2011 Jan; 29(1):46-51. PubMed ID: 21390419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis.
    Rong X; Yin J; Duan S; Sun Q; Babar ZU
    BMC Public Health; 2020 Apr; 20(1):588. PubMed ID: 32349722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicines prices in International (Geary-Khamis) Dollar. The comparison between regulated and deregulated markets.
    Zaprutko T; Cynar J; Sygit M; Stolecka A; Skorupska P; Jaszcz P; Kopciuch D; Paczkowska A; Ratajczak P; Kus K
    PLoS One; 2024; 19(6):e0304400. PubMed ID: 38848422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confidentiality agreements: a challenge in market regulation.
    Iunes RF; Uribe MV; Torres JB; Garcia MM; Dias CZ; Alvares-Teodoro J; de Assis Acurcio F; Guerra-Junior AA
    Int J Equity Health; 2019 Jun; 18(1):11. PubMed ID: 31155003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing Data Sources for Medicine Price Studies.
    Vogler S; Schneider P
    Int J Technol Assess Health Care; 2019 Jan; 35(2):106-115. PubMed ID: 30922418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
    Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
    PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
    Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.